NO862920L - Onkofetale spesifikke monoklonale antistoffer, fremgangsmaate for fremstilling og anvendelse. - Google Patents

Onkofetale spesifikke monoklonale antistoffer, fremgangsmaate for fremstilling og anvendelse.

Info

Publication number
NO862920L
NO862920L NO862920A NO862920A NO862920L NO 862920 L NO862920 L NO 862920L NO 862920 A NO862920 A NO 862920A NO 862920 A NO862920 A NO 862920A NO 862920 L NO862920 L NO 862920L
Authority
NO
Norway
Prior art keywords
oncopetal
procedure
manufacturing
monoclonal antibodies
specific monoclonal
Prior art date
Application number
NO862920A
Other languages
English (en)
Other versions
NO862920D0 (no
NO170691C (no
NO170691B (no
Inventor
Joseph H Coggin Jr
William J Payne Jr
Original Assignee
Univ South Alabama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ South Alabama filed Critical Univ South Alabama
Publication of NO862920L publication Critical patent/NO862920L/no
Publication of NO862920D0 publication Critical patent/NO862920D0/no
Publication of NO170691B publication Critical patent/NO170691B/no
Publication of NO170691C publication Critical patent/NO170691C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO862920A 1984-11-21 1986-07-18 Onkofoetale spesifikke monoklonale antistoffer og anvendelse derav NO170691C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/673,794 US4686180A (en) 1984-11-21 1984-11-21 Onco-fetal specific monoclonal antibodies, methods of preparation and use
PCT/US1985/002258 WO1986003223A1 (en) 1984-11-21 1985-11-15 Onco-fetal specific monoclonal antibodies, methods of preparation and use

Publications (4)

Publication Number Publication Date
NO862920L true NO862920L (no) 1986-07-18
NO862920D0 NO862920D0 (no) 1986-07-18
NO170691B NO170691B (no) 1992-08-10
NO170691C NO170691C (no) 1992-11-18

Family

ID=24704144

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862920A NO170691C (no) 1984-11-21 1986-07-18 Onkofoetale spesifikke monoklonale antistoffer og anvendelse derav

Country Status (9)

Country Link
US (1) US4686180A (no)
EP (1) EP0203967B1 (no)
JP (1) JPH0683666B2 (no)
AU (1) AU593229B2 (no)
CA (1) CA1307218C (no)
DE (1) DE3583296D1 (no)
FI (1) FI92222C (no)
NO (1) NO170691C (no)
WO (1) WO1986003223A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675287A (en) * 1984-07-26 1987-06-23 Scripps Clinic And Research Foundation Monoclonal antibody directed to human ganglioside GD2
FR2571146B1 (fr) * 1984-10-01 1988-02-26 Centre Nat Rech Scient Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
US5320941A (en) * 1986-06-06 1994-06-14 Dallan Young DNA sequence encoding mas onhcogene, polypeptides encoded therefrom and diagnostic and other methods based therefrom
JPH0859089A (ja) * 1994-08-18 1996-03-05 Towa Kogyo Kk ボビン搬送用トレイ
WO1997038089A1 (en) 1996-04-05 1997-10-16 South Alabama Medical Science Foundation Uses of oncofetal antigen specific cd4, cd8 cytotoxic and suppressor t cells and interleukin-10
US20030124125A1 (en) * 1996-04-05 2003-07-03 South Alabama Medical Science Foundation Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
DE10346627A1 (de) * 2003-10-08 2005-05-19 Weiss, Stefan, PD Dr. Single-chain-Antikörper gegen den 37 kDa/67 kDa Lamininrezeptor als Werkzeuge zur Diagnose und Therapie von Prionerkrankungen und Krebs, deren Herstellung und Verwendung
GB0510790D0 (en) 2005-05-26 2005-06-29 Syngenta Crop Protection Ag Anti-CD16 binding molecules
US20070048795A1 (en) * 2005-08-26 2007-03-01 Xiangming Fang Immunoaffinity separation and analysis compositions and methods
CA3209579A1 (en) 2021-01-27 2022-08-04 Innovent Biologics (Suzhou) Co., Ltd. Single-domain antibody against cd16a and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440863A (en) * 1978-02-22 1984-04-03 Duke University Breast cyst fluid protein assay
US4272504A (en) * 1978-12-14 1981-06-09 Abbott Laboratories Antibody adsorbed support method for carcinoembryonic antigen assay
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
EP0072902B1 (de) * 1981-08-21 1985-04-24 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Bestimmung von carcinoembryonalem Antigen (CEA) und zur Bestimmung geeignete Antikörperlösung
JPH0811075B2 (ja) * 1982-06-30 1996-02-07 雄治 松岡 単クローン性抗ｃｅａ抗体

Also Published As

Publication number Publication date
FI862978L (fi) 1986-07-18
JPS62501189A (ja) 1987-05-14
CA1307218C (en) 1992-09-08
NO862920D0 (no) 1986-07-18
EP0203967A4 (en) 1987-04-10
NO170691C (no) 1992-11-18
FI92222B (fi) 1994-06-30
EP0203967A1 (en) 1986-12-10
AU5196486A (en) 1986-06-18
FI92222C (fi) 1994-10-10
WO1986003223A1 (en) 1986-06-05
AU593229B2 (en) 1990-02-08
DE3583296D1 (de) 1991-07-25
EP0203967B1 (en) 1991-06-19
FI862978A0 (fi) 1986-07-18
US4686180A (en) 1987-08-11
JPH0683666B2 (ja) 1994-10-26
NO170691B (no) 1992-08-10

Similar Documents

Publication Publication Date Title
DE68914244D1 (de) Monoklonaler Antikörper.
DE3854502D1 (de) Gegen hiv-antigene spezifischer monoklonaler antikörper.
NO162179C (no) Monoklonale antistoffer for anvendelse in vitro.
DK299783D0 (da) Monoklont antistof, dets fremstilling og anvendelse
FI853283A7 (fi) Uudet monoklonaaliset glykokonjugaattien vasta-aineet, menetelmät niiden tuottamiseksi, ja niiden käytöt.
DE3885355D1 (de) Monoklonale Antikörper.
DE3788148D1 (de) Monoklonale Antikörper und deren Verwendung.
NO162797C (no) Monoklonalt antistofff for anvendelse in vitro.
DE3177276D1 (de) Monoklonale antikoerper.
NO862920D0 (no) Onkofetale spesifikke monoklonale antistoffer, fremgangsmaate for fremstilling og anvendelse.
DK188185D0 (da) Monoklonalt antistof
DE3583341D1 (de) Leberwurm-antigene.
DE3587714D1 (de) Menschliches alpha 2-Plasmin spezifischer monoklonaler Antikörper.
DE3780256D1 (de) Anti-pci-monoklonaler antikoerper.
DE3586808D1 (de) L-thyroxin erkennende monoklonale antikoerper.
DK144485A (da) Monoklonale antistoffer
DK37785D0 (da) Monoclonalt antistof
NO851386L (no) Fremgangsmaate for fremstilling av antigen.
IT8548762A0 (it) Linfochina, suo anticorpo specifico monoclonale e relativo procedimentodi produzione
NO890116D0 (no) Monoklonale antistoffer.
NO873488D0 (no) Monoklonale antistoffer.
DK270386A (da) Monoklonalt antistof til humant protein c, dets fremstilling og anvendelse
DE69023717D1 (de) Monoklonaler Antikörper.
FI893928A7 (fi) Monoklonala motkroppar.
DE3689183D1 (de) Monoklonaler Antiasialo-GM1-Antikörper.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2003